Results 121 to 130 of about 37,273 (171)

Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial.

JAMA Ophthalmol
Lee WK, Wong TY, Chen SJ, Sun X, Cheung CMG, Silva R, Ricci F, Zhang X, Machewitz T, Schulze A, Schmidt-Ott UM, Zhao M, Hasanbasic Z, Leal S, Iida T, PULSAR Study Investigators.   +15 more
europepmc   +1 more source

Six Cases of Polypoidal Choroidal Vasculopathy in Eyes with Choroidal Nevi. [PDF]

Case Rep Ophthalmol
Gaggino A, Inferrera L, Milan S, Presotto M, Tognetto D.   +4 more
europepmc   +1 more source

Prognostic factors in the treatment of polypoidal choroidal vasculopathy with conbercept: a post hoc analysis of the STAR study. [PDF]

Eye Vis (Lond)
Wang TI, Qu J, Tang R, Shi X, Ying X, Tao Y, Li X.   +6 more
europepmc   +1 more source

Fundus Autofluorescence (FAF) Alteration in Polypoidal Choroidal Vasculopathy (PCV) and Typical Neovascular Age Related Macular Degeneration (tAMD). [PDF]

Retina
Ong C, Sun C, Mathur R, Chan CM, Yeo I, Sim S, Teo K, Cheung G.   +7 more
europepmc   +1 more source

Switching to Faricimab for Polypoidal Choroidal Vasculopathy with Real-World Outcomes in Refractory Cases - The FAR-PEARL Study Report 1. [PDF]

Clin Ophthalmol
Fong KCS, Wong WJJ, Wong HS, Ling KP, Fong SN, Shunmugam M.   +5 more
europepmc   +1 more source

Efficacy and Safety of Ophthalmic Steroids in the Management of Polypoidal Choroidal Vasculopathy: A Systematic Review. [PDF]

Clin Ophthalmol
Adriono GA, Triyoga IF, Kadharusman MM, Victor AA, Djatikusumo A, Yudantha AR, Hutapea MM.   +6 more
europepmc   +1 more source

Early anatomical outcomes of faricimab vs aflibercept 2 mg in treatment-naïve neovascular age-related macular degeneration and polypoidal choroidal vasculopathy: A head-to-head comparative study in Taiwan. [PDF]

J Chin Med Assoc
Yang CC, Weng CC, Chou YB, Huang YM, Lin TC, Chen SJ, Hwang DK.   +6 more
europepmc   +1 more source

Intravitreal Aflibercept With vs Without Pneumatic Displacement for Submacular Hemorrhage Associated With Polypoidal Choroidal Vasculopathy. [PDF]

J Vitreoretin Dis
Wakabayashi T, Hara C, Shiraki A, Shiraki N, Fukushima Y, Sakimoto S, Sayanagi K, Nishida K, Sato S, Sakaguchi H, Nishida K.   +10 more
europepmc   +1 more source

Faricimab efficacy in a poorly responsive case of Polypoidal Choroidal Vasculopathy (PCV): A case report. [PDF]

Eur J Ophthalmol
Rizzo C, Savastano MC, Kilian R, Rizzo S.   +3 more
europepmc   +1 more source

Polypoidal choroidal vasculopathy with an exceptionally elevated pigment epithelial detachment. [PDF]

Am J Ophthalmol Case Rep
Li Y, Gabr H, Mieler WF.
europepmc   +1 more source